Back
Lantern Pharma, Inc. 10K Form
Sell
27
LTRN
Lantern Pharma, Inc.
Last Price:
$3.88
Seasonality Move:
3.04%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-03-10 | 10K | LTRN/Lantern Pharma, Inc. Annual |
| 2020-10-29 | 10Q | LTRN/Lantern Pharma, Inc. Quarterly |
| 2020-07-30 | 10Q | LTRN/Lantern Pharma, Inc. Quarterly |
Receive LTRN News And Ratings
See the #1 stock for the next 7 days that we like better than LTRN
LTRN Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-4.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.87 |
| Price / Book: | 4.37 |
Profitability
| EPS (TTM): | -1.75270 |
|---|---|
| Net Income (TTM): | $-18.9M |
| Gross Margin: | $-190.5K |
| Return on Equity: | -109.15% |
| Return on Assets: | -87.59% |
Lantern Pharma, Inc. Earnings Forecast
Key Lantern Pharma, Inc. Financial Ratios
-
Per Share Earnings over the last 7 years have been positive in 1 years.
Lantern Pharma, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | LTRN |
| Website: | lanternpharma.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 3.33 |
| Quick Ratio: | 3.06 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LTRN Technical Analysis vs Fundamental Analysis
Sell
27
Lantern Pharma, Inc. (LTRN)
is a Sell
Is Lantern Pharma, Inc. a Buy or a Sell?
-
Lantern Pharma, Inc. stock is rated a SellThe current Lantern Pharma, Inc. [LTRN] share price is $3.75. The Score for LTRN is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.